What is BellBrook Labs?
BellBrook Labs is a specialized provider of innovative biochemical assay solutions, primarily serving the drug discovery sector with a focus on enzyme drug targets. Their comprehensive product portfolio includes a wide array of high-throughput screening (HTS) assay kits, active enzymes, and bespoke assay development services. The company's clientele spans pharmaceutical corporations, biotechnology firms, and academic research institutions, all of whom benefit from BellBrook Labs' robust scientific expertise and support in enzyme kinetics. With a legacy of over two decades, BellBrook Labs is dedicated to furnishing high-quality data and thorough scientific assistance to propel research forward in critical areas such as oncology and autoimmune disease studies.
How much funding has BellBrook Labs raised?
BellBrook Labs has raised a total of $137K across 1 funding round:
Debt
$137K
Debt (2021): $137K with participation from PPP
Key Investors in BellBrook Labs
PPP
Public-Private Partnership
What's next for BellBrook Labs?
The recent strategic investment in BellBrook Labs signals a strong confidence in its ongoing mission to advance drug discovery through superior biochemical assay technology. As a company operating within a large-scale, late-stage funding environment, BellBrook Labs is well-positioned to scale its operations, enhance its research and development capabilities, and potentially expand its market reach. Future strategic initiatives are likely to involve further innovation in assay development, broadening the application of their enzyme-focused solutions, and strengthening partnerships within the pharmaceutical and biotech industries to accelerate the identification and development of novel therapeutics.
See full BellBrook Labs company page
